Hint mode is switched on Switch off
For swift navigation between sections

REGENTIS BIOMATERIALS

Organization name
REGENTIS BIOMATERIALS LTD.
Country name
Israel
Country of registration
Israel
Industry
Medical Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Awards

Documentation

IFRS/US GAAP reports

2025
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • SIC
    3842 ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001912966
Registration is required to get access.